REQUEST A DEMO
Total
USD $0.00
Search more companies

Memphis Pharmaceuticals & Chemical Industries Co. S.A.E. (Egypt)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Memphis Pharmaceuticals & Chemical Industries Co. S.A.E. Profile Updated: March 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Memphis Pharmaceuticals is one of the oldest operating pharmaceutical companies in Egypt since its incorporation in 1930. It is engaged in the research and development, production, trade, marketing and distribution of pharmaceutical products for human and veterinary use. The company is specialized in the production of medicines from the main therapeutic groups such as corticosteroids, vitamins, minerals, medicines for cardiac and vascular system, analgesics, antipyretics, etc. The company operates according to the international requirements and exports its products to more than 30 countries all over the worlds. Memphis Pharmaceutical has been ISO 9001:2008 and ISO 14001:2004 certified.

Headquarters
8 El - Sawah St., Hadayek El Qobba, Amryria, Po 92 - Elhelmiya
Cairo; Greater Cairo; Postal Code: 11281

Contact Details: Purchase the Memphis Pharmaceuticals & Chemical Industries Co. S.A.E. report to view the information.

Website: http://www.memphis.com.eg

Basic Information
Total Employees:
Purchase the Memphis Pharmaceuticals & Chemical Industries Co. S.A.E. report to view the information.
Outstanding Shares:
Purchase the Memphis Pharmaceuticals & Chemical Industries Co. S.A.E. report to view the information.
Registered Capital:
Purchase the Memphis Pharmaceuticals & Chemical Industries Co. S.A.E. report to view the information.
Financial Auditors:
Purchase the Memphis Pharmaceuticals & Chemical Industries Co. S.A.E. report to view the information.
Incorporation Date:
1991
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
60%
Subsidiaries
Holding Company for Pharmaceuticals
Company Performance
Financial values in the chart are available after Memphis Pharmaceuticals & Chemical Industries Co. S.A.E. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EGP. Absolute financial data is included in the purchased report.
Net sales revenue
42.01%
Total operating revenue
41.98%
Operating profit (EBIT)
192.43%
EBITDA
78.9%
Net Profit (Loss) for the Period
200.77%
Total assets
71.13%
Total equity
152.95%
Operating Profit Margin (ROS)
10.92%
Net Profit Margin
10.18%
Return on Equity (ROE)
8.9%
Debt to Equity Ratio
89.96%
Quick Ratio
-0.52%
Cash Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?